Abstract
Intravenous efgartigimod alfa (also known as efgartigimod alfa-fcab in the USA; Vyvgart (R)) is the first neonatal Fc receptor antagonist approved in ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
